Olariu AI - Search Results

1

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System.

Teal SB, Turok DK, Chen BA, Kimble T, Olariu AI, Creinin MD. Teal SB, et al. Among authors: olariu ai. Obstet Gynecol. 2019 Jan;133(1):63-70. doi: 10.1097/AOG.0000000000003034. Obstet Gynecol. 2019. PMID: 30531565 Free PMC article. Clinical Trial.

2

Levonorgestrel release rates over 5 years with the Liletta® 52-mg intrauterine system.

Creinin MD, Jansen R, Starr RM, Gobburu J, Gopalakrishnan M, Olariu A. Creinin MD, et al. Contraception. 2016 Oct;94(4):353-6. doi: 10.1016/j.contraception.2016.04.010. Epub 2016 Apr 25. Contraception. 2016. PMID: 27125892 Clinical Trial.

3

Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use.

Darney PD, Stuart GS, Thomas MA, Cwiak C, Olariu A, Creinin MD. Darney PD, et al. Contraception. 2018 Mar;97(3):210-214. doi: 10.1016/j.contraception.2017.10.005. Epub 2017 Oct 13. Contraception. 2018. PMID: 29038072 Clinical Trial.

4

Bleeding patterns for the Liletta^® levonorgestrel 52 mg intrauterine system.

Schreiber CA, Teal SB, Blumenthal PD, Keder LM, Olariu AI, Creinin MD. Schreiber CA, et al. Among authors: olariu ai. Eur J Contracept Reprod Health Care. 2018 Apr;23(2):116-120. doi: 10.1080/13625187.2018.1449825. Epub 2018 Mar 21. Eur J Contracept Reprod Health Care. 2018. PMID: 29560743 Clinical Trial.

5

Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system.

Westhoff CL, Keder LM, Gangestad A, Teal SB, Olariu AI, Creinin MD. Westhoff CL, et al. Among authors: olariu ai. Contraception. 2020 Mar;101(3):159-161. doi: 10.1016/j.contraception.2019.10.010. Epub 2019 Nov 28. Contraception. 2020. PMID: 31786203

6

Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding.

Chen BA, Eisenberg DL, Schreiber CA, Turok DK, Olariu AI, Creinin MD. Chen BA, et al. Among authors: olariu ai. Am J Obstet Gynecol. 2020 Apr;222(4S):S888.e1-S888.e6. doi: 10.1016/j.ajog.2019.11.1288. Epub 2019 Dec 19. Am J Obstet Gynecol. 2020. PMID: 31866516

7

Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuation.

Carr BR, Thomas MA, Gangestad A, Eisenberg DL, Olariu A, Creinin MD. Carr BR, et al. Contraception. 2021 Jan;103(1):26-31. doi: 10.1016/j.contraception.2020.09.005. Epub 2020 Oct 8. Contraception. 2021. PMID: 33038303 Clinical Trial.

8

Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years.

Gilliam ML, Jensen JT, Eisenberg DL, Thomas MA, Olariu A, Creinin MD. Gilliam ML, et al. Contraception. 2021 Jun;103(6):444-449. doi: 10.1016/j.contraception.2021.02.013. Epub 2021 Feb 28. Contraception. 2021. PMID: 33651995 Clinical Trial.

9

Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use.

Creinin MD, Schreiber CA, Turok DK, Cwiak C, Chen BA, Olariu AI. Creinin MD, et al. Among authors: olariu ai. Am J Obstet Gynecol. 2022 Dec;227(6):871.e1-871.e7. doi: 10.1016/j.ajog.2022.05.022. Epub 2022 May 13. Am J Obstet Gynecol. 2022. PMID: 35569516 Free article.

10

Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use.

Chen BA, Kimble T, Harris LH, Kerns JL, Olariu AI, Creinin MD. Chen BA, et al. Among authors: olariu ai. Obstet Gynecol. 2023 May 1;141(5):1004-1006. doi: 10.1097/AOG.0000000000005147. Epub 2023 Apr 5. Obstet Gynecol. 2023. PMID: 37023451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page